Related Experiment Video
Updated: Jun 6, 2025

Brain Morphology of Cannabis Users With or Without Psychosis: A Pilot MRI Study
Published on: August 18, 2020
Understanding Older Adults' Experiences with Cannabis for Medicinal Purposes: A Mixed Methods Study
Sherry Dahlke1, Jeffrey I Butler1, Madeline Toubiana2
1Faculty of Nursing, University of Alberta, EdmontonT6G 1C9, AB, Canada.
Abstract:
The aim of this study was to explore the perspectives of older medicinal cannabis consumers and those advising them on older Canadians' experiences accessing cannabis and information about it, as well as how stigma may influence their experiences. A concurrent triangulation mixed methods design was used. The design was qualitatively driven and involved conducting semi-structured interviews with older adults and advisors and developing a survey for older adults. We used a Qualitative Descriptive approach for the analysis of qualitative data and descriptive statistics for quantitative survey data. Findings demonstrate that many older adults are accessing information about cannabis for medical purposes from retailers, either because they are reticent to talk to their healthcare professionals or were rebuffed when bringing up the subject. We recommend cannabis education be required for healthcare professionals working with older persons and that future research examines their perspectives on medicinal cannabis and older adults.
More Related Videos
Related Concept Videos
Longitudinal Research
Factors Affecting Drug Response: Overview
Altered States of Awareness
The ingestion of substances like stimulants or hallucinogens leads to chemical alterations in the brain...
Hallucinogens and Psychedelics
Marijuana, derived from the dried leaves and flowers of the hemp plant, contains...
Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
Two synthetic agonists of THC,...
Crossover Experiments
Crossover designs are performed even with smaller sample sizes since the samples can act as their controls. These are better than simple randomized trials since patients are exposed to all the treatments.

